The pregnant women living with hiv antiretroviral therapy coverage for pmtct in Angola is now 80%, marking a 5% (6.7%) increase compared to 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Angola
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Angola
PMTCT antiretroviral therapy coverage
More indicators for Angola
Male unintentional poisoning
2.6
-0.1
(2019)
Female wasting in children
4.3%
-3.4%
(2015)
Female prevalence of HIV
0.7%
-0.1%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar46
-intl dollar9
(2021)
Birth registration
25%
-10.6%
(2016)
Contraceptive modern method prevalence
12.5%
+0.8%
(2016)
Angola PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 80% | +5% |
| 2021 | 75% | +9% |
| 2020 | 66% | +8% |
| 2019 | 58% | +22% |
| 2018 | 36% | +10% |
| 2017 | 26% | -1% |
| 2016 | 27% | -3% |
| 2015 | 30% | -1% |
| 2014 | 31% | +11% |
| 2013 | 20% | +8% |
| 2012 | 12% | +2% |
| 2011 | 10% | -4% |
| 2010 | 14% | +2% |
| 2009 | 12% | +1% |
| 2008 | 11% | +2% |
| 2007 | 9% | 0% |
| 2006 | 9% | +7% |
| 2005 | 2% | +1% |
| 2004 | 1% | +1% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |